Chronic liver disease. Chronic passive congestion of liver
Conditions
Interventions
Intervention 1: Control group: popular drugs using for liver cirrhosis. Intervention 2: Intervention group: popular drugs using for liver cirrhosis and 50000 units of vitamin D on a daily basis for th
Treatment - Drugs
Control group: popular drugs using for liver cirrhosis
Intervention group: popular drugs using for liver cirrhosis and 50000 units of vitamin D on a daily basis for three months
Sponsors
Vice Chancellor for Research, Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 139 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: All the decompensated cirrhosis patients (CHILD=7) admitted to hospital or referred to Gastroenterology Clinics; aged more than 18 years; and consent to participate in the study. Exclusion criteria: Human immunodeficiency virus patients; renal failure due to reasons other than liver failure; malabsorption such as chronic diarrhea, celiac, chronic pancreatitis; patients undergoing corticosteroid treatment; pregnancy; and cirrhosis patients secondary to cholestasis such as primary biliary cirrhosis
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver function. Timepoint: 3 months after intervention. Method of measurement: MELD scoring system; according to levels of bilirubin and creatinine serum. | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver function. Timepoint: 3 months after intervention. Method of measurement: Child-Pugh scoring system; classifies the severity of liver diseases into five categories. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Ali Abbasi
Mashhad University of Medical Sciences
Outcome results
None listed